![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: Adis International
ISSN: 1173-8324
Source: Inpharma, Vol.1, Iss.1327, 2002-01, pp. : 20-20
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Alteplase cost effective in acute MI vs streptokinase
Inpharma, Vol. 1, Iss. 1366, 2002-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Eplerenone reduces morbidity, mortality after acute MI
Inpharma, Vol. 1, Iss. 1382, 2003-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Alteplase underused in acute ischaemic stroke
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 331, 2001-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Intravenous alteplase for acute ischaemic stroke
Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 15, 2005-12 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Alteplase underused in acute ischaemic stroke
Inpharma, Vol. 1, Iss. 1306, 2001-01 ,pp. :